Eslicarbazepine acetate
BIA
S-(-)-10-acetoxy-10,11-dihydro-5H-dibenzo/b
f/azepine-5-carboxamide
antiepileptic drug
Phase III clinical trials
improving
efficacy
safety
comparison
structurally
drugs carbamazepine
CBZ
oxcarbazepine
OXC
effects of
oral
eslicarbazepine acetate
whole-animal model
partial
seizures
elicited
days
changes
threshold
seizure
patterns
animals
treated with
threshold
doses
picrotoxin
seizures
average
seizure
duration
Pre-treatment
dose
picrotoxin microperfusion
seizures
rats
Lower doses
suppress
seizures
administration
reductions
seizures
duration
seizure number
adverse effects
eslicarbazepine acetate
behavioral/EEG
sleep/wakefulness cycle
doses
